DE69919554D1 - Systeme zur arzneistoffabgabe an schleimhäute - Google Patents

Systeme zur arzneistoffabgabe an schleimhäute

Info

Publication number
DE69919554D1
DE69919554D1 DE69919554T DE69919554T DE69919554D1 DE 69919554 D1 DE69919554 D1 DE 69919554D1 DE 69919554 T DE69919554 T DE 69919554T DE 69919554 T DE69919554 T DE 69919554T DE 69919554 D1 DE69919554 D1 DE 69919554D1
Authority
DE
Germany
Prior art keywords
delivery
systems
mucous membranes
medicinal products
mucosal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69919554T
Other languages
English (en)
Other versions
DE69919554T2 (de
Inventor
J Matson
Yen-Lane Chen
T Ruth
R Benes
G Burgaud
L Horriere
M Seyler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Application granted granted Critical
Publication of DE69919554D1 publication Critical patent/DE69919554D1/de
Publication of DE69919554T2 publication Critical patent/DE69919554T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/38Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DE69919554T 1998-10-02 1999-10-01 Systeme zur arzneistoffabgabe an schleimhäute Expired - Fee Related DE69919554T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10295698P 1998-10-02 1998-10-02
US102956P 1998-10-02
PCT/US1999/022967 WO2000019987A1 (en) 1998-10-02 1999-10-01 Mucosal originated drug delivery systems and animal applications

Publications (2)

Publication Number Publication Date
DE69919554D1 true DE69919554D1 (de) 2004-09-23
DE69919554T2 DE69919554T2 (de) 2005-09-01

Family

ID=22292601

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69919554T Expired - Fee Related DE69919554T2 (de) 1998-10-02 1999-10-01 Systeme zur arzneistoffabgabe an schleimhäute

Country Status (19)

Country Link
EP (1) EP1117390B1 (de)
JP (1) JP2002526403A (de)
KR (1) KR20010075528A (de)
CN (1) CN1321086A (de)
AT (1) ATE273698T1 (de)
AU (1) AU768040B2 (de)
BR (1) BR9915020A (de)
CA (1) CA2345808A1 (de)
CZ (1) CZ20011188A3 (de)
DE (1) DE69919554T2 (de)
ES (1) ES2228125T3 (de)
HU (1) HUP0103543A2 (de)
IL (1) IL142168A0 (de)
MX (1) MXPA01003310A (de)
NO (1) NO20011656L (de)
NZ (1) NZ510771A (de)
PL (1) PL347061A1 (de)
PT (1) PT1117390E (de)
WO (1) WO2000019987A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
DE10107659B4 (de) * 2001-02-19 2008-03-13 Lts Lohmann Therapie-Systeme Ag Mucoadhäsive zerfallsfähige Arzneizubereitung zur Wirkstoffverabreichung in der Veterinär- und Humanmedizin
BRPI0414856A (pt) 2003-10-03 2006-11-21 3M Innovative Properties Co imidazoquinolinas alcóxi-substituìdas
KR101130928B1 (ko) 2003-11-25 2012-04-12 쓰리엠 이노베이티브 프로퍼티즈 컴파니 치환된 이미다조 고리 시스템 및 방법
FI20041425A0 (fi) 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
JP2008530022A (ja) 2005-02-04 2008-08-07 コーリー ファーマシューティカル グループ,インコーポレイテッド 免疫反応調節物質を含む水性ゲル処方物
JP2006335640A (ja) * 2005-05-06 2006-12-14 Daicho Kikaku:Kk 動物用薬剤
WO2007013590A1 (ja) * 2005-07-29 2007-02-01 Santen Pharmaceutical Co., Ltd. 固形組成物を用いた後眼部組織への非侵襲性ドラッグデリバリーシステム
WO2007103511A1 (en) * 2006-03-07 2007-09-13 Oramelts International, Inc. Multi-layer medical patch with impermeable center
SI2054031T1 (sl) 2006-07-21 2016-09-30 Biodelivery Sciences International, Inc. Transmukozne naprave za administracijo z izboljšanim vnosom
DE202008017304U1 (de) 2008-02-29 2009-08-27 Acino Ag Oral zerfallender Film zur therapeutischen Anwendung von Antiparasitika bei Tieren
CN106511273A (zh) * 2009-05-15 2017-03-22 瑞克欧制药有限公司 舌下右美托咪定组合物及其使用方法
AU2010273382A1 (en) * 2009-07-17 2012-02-02 The Board Of Regents For Oklahoma State University Supralingual vaccines and applicators
EP2570217B1 (de) 2011-09-15 2014-11-05 Klingelnberg AG Semi-Completing Wälzschälverfahren und Vorrichtung mit entsprechendem Wälzschälwerkzeug zum Ausführen eines Semi-Completing Wälzschälverfahrens
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
CA2924236C (en) 2013-10-07 2020-01-07 Teikoku Pharma Usa, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
CN105682650B (zh) * 2013-10-07 2020-09-25 帝国制药美国公司 用于使用非镇静性右旋美托咪啶经皮组合物治疗戒断综合征的方法和组合物
CA2924188C (en) * 2013-10-07 2018-12-18 Teikoku Pharma Usa, Inc. Methods and compositions for managing pain comprising dexmedetomidine transdermal compositions
ES2856189T3 (es) 2013-10-07 2021-09-27 Teikoku Pharma Usa Inc Métodos y composiciones para el tratamiento del trastorno de hiperactividad por déficit de atención, ansiedad e insomnio utilizando composiciones transdérmicas de dexmedetomidina
KR101827980B1 (ko) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 덱스메데토미딘 경피 전달 장치 및 이의 사용 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
GB1455251A (en) * 1972-08-25 1976-11-10 Evode Ltd Method of sealing gaps and compositions therefor heat
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
FR2712807B1 (fr) * 1993-11-24 1996-02-23 Vetoquinol Sa Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale .
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine

Also Published As

Publication number Publication date
NZ510771A (en) 2003-08-29
ES2228125T3 (es) 2005-04-01
DE69919554T2 (de) 2005-09-01
EP1117390B1 (de) 2004-08-18
BR9915020A (pt) 2001-08-14
WO2000019987A1 (en) 2000-04-13
PT1117390E (pt) 2005-01-31
NO20011656D0 (no) 2001-04-02
CA2345808A1 (en) 2000-04-13
MXPA01003310A (es) 2003-05-15
NO20011656L (no) 2001-04-02
AU1100100A (en) 2000-04-26
HUP0103543A2 (hu) 2002-01-28
PL347061A1 (en) 2002-03-11
AU768040B2 (en) 2003-11-27
JP2002526403A (ja) 2002-08-20
KR20010075528A (ko) 2001-08-09
CN1321086A (zh) 2001-11-07
EP1117390A1 (de) 2001-07-25
ATE273698T1 (de) 2004-09-15
CZ20011188A3 (cs) 2001-08-15
IL142168A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
DE69919554D1 (de) Systeme zur arzneistoffabgabe an schleimhäute
ATE429922T1 (de) Topische gel-abgabesysteme zur behandlung von hauterkrankungen
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
GEP20053602B (en) Aripiprazole for Oral Administration
ES2167717T3 (es) Nuevos aminoacidos ciclicos sustituidos como agentes farmaceuticos.
ATE527010T1 (de) Vorrichtung zur verabreichung von co
HK1096857A1 (en) Medicamentously targeted local lipolysis
DE60122672D1 (de) Zusammensetzung zur intestinalen verabreichung
ATE447403T1 (de) Cannabinoiden zur behandlung von während des schlafens auftretenden atmungsstörungen
DE69624355D1 (de) Verfahren zur arzneistoffabgabe mittels gentherapie
ATE249835T1 (de) Immunoregulator
ATE241338T1 (de) Arzneistoffabgabesystem, insbesondere zur verabreichung von androgenen
ATE319473T1 (de) Melagatran zur behandlung von entzündungen
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
CA2285477A1 (en) Formulations and methods to treat and prevent equine protozoal myeloencephalitis
DE69929616D1 (de) Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen
MX9803610A (es) Utilizacion de flupirtina para la profilaxis y la terapia de enfermedades que van a compañadas de un deterioro del sistema celular hermatopoyetico.
DE60039579D1 (de) Humane adulte astrozyten, sowie deren herstellung und verwendung
ATE261724T1 (de) Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen
UA31156A (uk) Спосіб лікування пневмоентеритів телят
AU2396900A (en) Treatment and prevention of hiv and other viral infections
DE9405351U1 (de) Vorrichtung zur Herstellung transdermaler therapeutischer Systeme
FR2783396B1 (fr) Dispositif de diffusion lente de produits de traitement, notamment phytosanitaires
RU94020597A (ru) Способ лечения псевдотуберкулеза
UA29004A (uk) Спосіб лікування сепсису

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee